{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:26:40Z","timestamp":1792099600334,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00228-024-03775-6","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T01:45:30Z","timestamp":1731894330000},"page":"83-91","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effectiveness of macrolides as add-on therapy to beta-lactams in community-acquired pneumonia: A meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7974-0068","authenticated-orcid":false,"given":"Vit\u00f3ria Martins","family":"Priz\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2237-2799","authenticated-orcid":false,"given":"Otavio Cosendey","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7345-0751","authenticated-orcid":false,"given":"Beatriz Austreg\u00e9silo de Athayde","family":"de Hollanda Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0788-130X","authenticated-orcid":false,"given":"Beatriz Ximenes","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0524-5616","authenticated-orcid":false,"given":"Maria Luiza Rodrigues","family":"Defante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4506-0472","authenticated-orcid":false,"given":"Mariana","family":"de Moura Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"issue":"3","key":"3775_CR1","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1177\/0300060518819381","volume":"47","author":"H Lu","year":"2019","unstructured":"Lu H, Zeng N, Chen Q, Wu Y, Cai S, Li G et al (2019) Clinical prognostic significance of serum high mobility group box-1 protein in patients with community-acquired pneumonia. J Int Med Res 47(3):1232\u20131240","journal-title":"J Int Med Res"},{"issue":"1","key":"3775_CR2","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1080\/14760584.2023.2261785","volume":"22","author":"E Tsoumani","year":"2023","unstructured":"Tsoumani E, Carter JA, Salomonsson S, Stephens JM, Bencina G (2023) Clinical, economic, and humanistic burden of community acquired pneumonia in Europe: a systematic literature review. Expert Rev Vaccines 22(1):876\u2013884","journal-title":"Expert Rev Vaccines"},{"key":"3775_CR3","unstructured":"Regunath H, Oba Y (2024) Treasure Island (FL): StatPearls Publishing. StatPearls [Internet]."},{"issue":"1","key":"3775_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12931-018-0781-4","volume":"19","author":"DC Marshall","year":"2018","unstructured":"Marshall DC, Goodson RJ, Xu Y, Komorowski M, Shalhoub J, Maruthappu M et al (2018) Trends in mortality from pneumonia in the Europe union: a temporal analysis of the European detailed mortality database between 2001 and 2014. Respir Res 19(1):81","journal-title":"Respir Res"},{"issue":"10","key":"3775_CR5","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.jiac.2021.06.003","volume":"27","author":"A Ito","year":"2021","unstructured":"Ito A, Ishida T, Tachibana H, Nakanishi Y, Tokioka F, Yamazaki A et al (2021) Usefulness of \u03b2-lactam and macrolide combination therapy for treating community-acquired pneumonia patients hospitalized in the intensive care unit: propensity score analysis of a prospective cohort study. J Infect Chemother 27(10):1447\u20131453","journal-title":"J Infect Chemother"},{"issue":"6","key":"3775_CR6","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00134-023-07033-8","volume":"49","author":"I Martin-Loeches","year":"2023","unstructured":"Martin-Loeches I, Torres A, Nagavci B, Aliberti S, Antonelli M, Bassetti M et al (2023) ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med 49(6):615\u2013632","journal-title":"Intensive Care Med"},{"issue":"4","key":"3775_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S2213-2600(23)00412-5","volume":"12","author":"EJ Giamarellos-Bourboulis","year":"2024","unstructured":"Giamarellos-Bourboulis EJ, Siampanos A, Bolanou A, Doulou S, Kakavoulis N, Tsiakos K et al (2024) Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med 12(4):294\u2013304","journal-title":"Lancet Respir Med"},{"key":"3775_CR8","doi-asserted-by":"crossref","unstructured":"Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M et al (2012) Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database Syst Rev 2012(9):CD004418","DOI":"10.1002\/14651858.CD004418.pub4"},{"key":"3775_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jgar.2022.05.009","volume":"30","author":"LY Xu","year":"2022","unstructured":"Xu LY, Wang CC, Peng XX, Jiao Y, Zhao CZ, Zhang L et al (2022) Empirical antibiotic treatment strategies for community-acquired pneumonia: a network meta-analysis. J Glob Antimicrob Resist 30:1\u20139","journal-title":"J Glob Antimicrob Resist"},{"issue":"6","key":"3775_CR10","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/jac\/dku033","volume":"69","author":"W Nie","year":"2014","unstructured":"Nie W, Li B, Xiu Q (2014) \u03b2-Lactam\/macrolide dual therapy versus \u03b2-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis. J Antimicrob Chemother 69(6):1441\u20131446","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"3775_CR11","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/resp.12835","volume":"21","author":"N Horita","year":"2016","unstructured":"Horita N, Otsuka T, Haranaga S, Namkoong H, Miki M, Miyashita N et al (2016) Beta-lactam plus macrolides or beta-lactam alone for community-acquired pneumonia: a systematic review and meta-analysis. Respirology 21(7):1193\u20131200","journal-title":"Respirology"},{"key":"3775_CR12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"29","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 29:n71","journal-title":"BMJ"},{"key":"3775_CR13","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ et al (eds) (2023) Cochrane handbook for systematic reviews of interventions version 6.4. 6.4. Cochrane.\u00a0Available from: www.training.cochrane.org\/handbook"},{"key":"3775_CR14","unstructured":"Mirabile VS, Shebl E, Sankari A, et al. (2023) StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Respiratory Failure in Adults."},{"issue":"1","key":"3775_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol 14(1):135","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"3775_CR16","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1177\/0962280216669183","volume":"27","author":"D Luo","year":"2018","unstructured":"Luo D, Wan X, Liu J, Tong T (2018) Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range. Stat Methods Med Res 27(6):1785\u20131805","journal-title":"Stat Methods Med Res"},{"issue":"5","key":"3775_CR17","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/jrsm.1429","volume":"11","author":"J Shi","year":"2020","unstructured":"Shi J, Luo D, Weng H, Zeng X, Lin L, Chu H et al (2020) Optimally estimating the sample standard deviation from the five-number summary. Res Synth Methods 11(5):641\u2013654","journal-title":"Res Synth Methods"},{"issue":"7","key":"3775_CR18","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1177\/09622802231172043","volume":"32","author":"J Shi","year":"2023","unstructured":"Shi J, Luo D, Wan X, Liu Y, Liu J, Bian Z et al (2023) Detecting the skewness of data from the five-number summary and its application in meta-analysis. Stat Methods Med Res 32(7):1338\u20131360","journal-title":"Stat Methods Med Res"},{"key":"3775_CR19","first-page":"14898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:14898","journal-title":"BMJ"},{"issue":"14","key":"3775_CR20","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1056\/NEJMoa1406330","volume":"372","author":"DF Postma","year":"2015","unstructured":"Postma DF, van Werkhoven CH, van Elden LJR, Thijsen SFT, Hoepelman AIM, Kluytmans JAJW et al (2015) Antibiotic treatment strategies for community-acquired pneumonia in adults. N Engl J Med 372(14):1312\u20131323","journal-title":"N Engl J Med"},{"issue":"2","key":"3775_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.53350\/pjmhs2023172182","volume":"17","author":"L Riaz","year":"2023","unstructured":"Riaz L, Gebril MF, Rasheed T, Javed M, Naveed M, Riaz Z (2023) Comparative effectiveness of ceftriaxone alone and in combination with clarithromycin for paediatric patients hospitalized with community acquired pneumonia. Pak J Med Health Sci 17(2):182\u2013183","journal-title":"Pak J Med Health Sci"},{"issue":"Suppl 54","key":"3775_CR22","first-page":"3006","volume":"36","author":"ON Hatipoglu","year":"2010","unstructured":"Hatipoglu ON, Uysal S, Altiay G, Sut N, Tabakoglu E (2010) The effect of addition of macrolide to a beta-lactam antibiotic on treatment success in patients with moderately severe community acquired pneumonia. Eur Respir J Istanbul 36(Suppl 54):3006","journal-title":"Eur Respir J Istanbul"},{"issue":"12","key":"3775_CR23","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1001\/jamainternmed.2014.4887","volume":"174","author":"N Garin","year":"2014","unstructured":"Garin N, Genn\u00e9 D, Carballo S, Chuard C, Eich G, Hugli O et al (2014) \u03b2-lactam monotherapy vs \u03b2-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial. JAMA Intern Med 174(12):1894\u20131901","journal-title":"JAMA Intern Med"},{"issue":"2","key":"3775_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cmi.2017.06.013","volume":"24","author":"C Figueiredo-Mello","year":"2018","unstructured":"Figueiredo-Mello C, Naucler P, Negra MD, Levin AS (2018) Ceftriaxone versus ceftriaxone plus a macrolide for community-acquired pneumonia in hospitalized patients with HIV\/AIDS: a randomized controlled trial. Clin Microbiol Infect 24(2):146\u2013151","journal-title":"Clin Microbiol Infect"},{"key":"3775_CR25","unstructured":"Patel PH, Hashmi MF (2023) StatPearls [Internet]. Macrolides. [Updated 2023 May 16]."},{"issue":"8","key":"3775_CR26","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/milmed\/165.8.636","volume":"165","author":"DA Williams","year":"2000","unstructured":"Williams DA (2000) Stevens-Johnson syndrome after erythromycin therapy while deployed at sea. Mil Med 165(8):636\u2013637","journal-title":"Mil Med"},{"key":"3775_CR27","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.3390\/microorganisms10122326","volume":"10","author":"N Garin","year":"2022","unstructured":"Garin N, Marti C, Skali Lami A, Prendki V (2022) Atypical pathogens in adult community-acquired pneumonia and implications for empiric antibiotic treatment: a narrative review. Microorganisms 10:2326","journal-title":"Microorganisms"},{"issue":"9560","key":"3775_CR28","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S0140-6736(07)60235-9","volume":"369","author":"S Malhotra-Kumar","year":"2007","unstructured":"Malhotra-Kumar S, Lammens C, Coenen S, Van Herck K, Goossens H (2007) Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet 369(9560):482\u2013490","journal-title":"Lancet"},{"issue":"1","key":"3775_CR29","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1186\/s40064-015-1398-4","volume":"4","author":"P Ferrer","year":"2015","unstructured":"Ferrer P, Sabat\u00e9 M, Ballar\u00edn E, Fortuny J, Rottenkolber M, Schmiedl S et al (2015) Sales of macrolides, lincosamides, streptogramins, and amoxicillin\/clavulanate in the in- and outpatient setting in 10 European countries, 2007\u20132010. Springerplus 4(1):612","journal-title":"Springerplus"},{"issue":"1","key":"3775_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-018-0384-3","volume":"7","author":"P Shrestha","year":"2018","unstructured":"Shrestha P, Cooper BS, Coast J, Oppong R, Do Thi Thuy N, Phodha T et al (2018) Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use. Antimicrob Resist Infect Control 7(1):1\u20139","journal-title":"Antimicrob Resist Infect Control"},{"key":"3775_CR31","doi-asserted-by":"publisher","first-page":"f1235","DOI":"10.1136\/bmj.f1235","volume":"346","author":"S Schembri","year":"2013","unstructured":"Schembri S, Williamson PA, Short PM, Singanayagam A, Akram A, Taylor J et al (2013) Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies. BMJ 346:f1235\u2013f1235","journal-title":"BMJ"},{"issue":"10","key":"3775_CR32","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1164\/rccm.201402-0385CI","volume":"189","author":"RK Albert","year":"2014","unstructured":"Albert RK, Schuller JL, COPD Clinical Research Network (2014) Macrolide antibiotics and the risk of cardiac arrhythmias. Am J Respir Crit Care Med 189(10):1173\u201380","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3775_CR33","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/lary.26799","volume":"128","author":"AK Ikeda","year":"2018","unstructured":"Ikeda AK, Prince AA, Chen JX, Lieu JEC, Shin JJ (2018) Macrolide-associated sensorineural hearing loss: a systematic review. Laryngoscope 128(1):228\u2013236","journal-title":"Laryngoscope"},{"issue":"4","key":"3775_CR34","doi-asserted-by":"publisher","first-page":"e066721","DOI":"10.1136\/bmjopen-2022-066721","volume":"13","author":"S Wang","year":"2023","unstructured":"Wang S, Tang J, Tan Y, Song Z, Qin L (2023) Prevalence of atypical pathogens in patients with severe pneumonia: a systematic review and meta-analysis. BMJ Open 13(4):e066721","journal-title":"BMJ Open"}],"updated-by":[{"DOI":"10.1007\/s00228-025-03834-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000}}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03775-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-024-03775-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-024-03775-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T23:45:15Z","timestamp":1744242315000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-024-03775-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3775"],"URL":"https:\/\/doi.org\/10.1007\/s00228-024-03775-6","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00228-025-03834-6","asserted-by":"object"}]},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00228-025-03834-6","URL":"https:\/\/doi.org\/10.1007\/s00228-025-03834-6","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}